Different sensitivity to the motor incoordinating effects of γ-hydroxybutyric acid (GHB) and baclofen in GHB-sensitive and GHB-resistant rats

[1]  G. Engberg,et al.  The GABAB-receptor antagonist, CGP 35348, antagonises γ-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice , 2005, Journal of Neural Transmission.

[2]  G. Gessa,et al.  Completion by the 10th generation of the bidirectional selective breeding of GHB-sensitive and GHB-resistant rats. , 2004, Brain research. Brain research protocols.

[3]  A. Woolf,et al.  Enzyme and Receptor Antagonists for Preventing Toxicity from the Gamma‐Hydroxybutyric Acid Precursor 1,4‐Butanediol in CD‐1 Mice , 2002, Annals of the New York Academy of Sciences.

[4]  G. Gessa,et al.  Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into γ-hydroxybutyric acid , 2002 .

[5]  G. Tunnicliff.  Gamma-Hydroxybutyrate: Molecular, functional and clinical aspects , 2002 .

[6]  G. Gessa,et al.  Role of GABAB receptors in the sedative/hypnotic effect of γ-hydroxybutyric acid , 2001 .

[7]  G. Gessa,et al.  Procedure of bidirectional selective outbreeding for production of two rat lines differing in sensitivity to the sedative/hypnotic effect of gamma-hydroxybutyric acid. , 2001, Brain research. Brain research protocols.

[8]  G. Gessa,et al.  Selective breeding of two rat lines differing in sensitivity to GHB and baclofen , 2001, Brain Research.

[9]  B. Tabakoff,et al.  Neurohypophyseal peptides maintain tolerance to the incoordinating effects of ethanol , 1984, Pharmacology Biochemistry and Behavior.